According to Global Blue Group's latest financial reports the company's current EPS (TTM) is NZ$0.63. an increase over its 2023 EPS that were of NZ-$0.22.
Year | EPS | Change |
---|---|---|
2024 | NZ$0.11 | -149.68% |
2023 | NZ-$0.22 | -75.97% |
2022 | NZ-$0.91 | -79.71% |
2021 | NZ-$4.49 | 11935.17% |
2020 | NZ-$0.03728 | -297.97% |
2019 | NZ$0.01883 | -89.81% |
2018 | NZ$0.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Boston Scientific BSX | NZ$2.32 | 267.24% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | NZ$12.57 | 1,893.19% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | NZ$11.76 | 1,765.45% | ๐บ๐ธ USA |
![]() Medtronic MDT | NZ$5.54 | 778.17% | ๐ฎ๐ช Ireland |
![]() Johnson & Johnson JNJ | NZ$15.21 | 2,313.03% | ๐บ๐ธ USA |